Safe to save blood in ovarian cancer surgery – time to change transfusion habits
DOI:
https://doi.org/10.2340/1651-226X.2024.40435Keywords:
ovarian cancer, ppatient blood management, red blood cell transfusion, intravenous iron, hemoglobin levelAbstract
Background: Patients with advanced ovarian cancer (AOC) undergoing surgery are often subjected to red blood cell (RBC) transfusions. Both anemia and RBC transfusion are associated with increased morbidity. The aim was to evaluate patient recovery after the implementation of patient blood management (PBM) strategies.
Methods: This retrospective cohort study included 354 patients with AOC undergoing surgery at Skane University Hospital Lund, Sweden, between January 2016 and December 2021. The gradual implementation of PBM strategies included restrictive RBC transfusion, tranexamic acid as standard medication before laparotomies and intravenous iron administered to patients with iron deficiency. Severe complications were defined as Clavien-Dindo (CD) grade ≥ 3a. Logistic and linear regression analyses were used to evaluate the differences between three consecutive periods.
Results: After the implementation of new strategies, 52% of the patients had at least one transfusion compared to 83% at baseline (p < 0.001). There was no difference in the rate of severe complications (CD ≥ 3a) between the groups, adjusted odds ratio 0.55 (95% CI 0.26–1.17). The mean difference in hemoglobin before chemotherapy was -1.32 g/L (95% CI -3.04 to -0.22) when adjusted for blood loss and days from surgery to chemotherapy. The length of stay (LOS) decreased from 8.5 days to 7.5 days (p 0.002).
Interpretation: The number of patients transfused were reduced by 31%. Despite a slight increase in anemia rate, severe complications (CD ≥ 3a) remained stable. The LOS was reduced, and chemotherapy was given without delay, indicating that PBM is feasible and without causing major severe effects on short-term recovery.
Downloads
References
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.
https://doi.org/10.3322/caac.21456 DOI: https://doi.org/10.3322/caac.21456
du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115(6):1234–44.
https://doi.org/10.1002/cncr.24149 DOI: https://doi.org/10.1002/cncr.24149
Lundin ES, Johansson T, Zachrisson H, et al. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. Acta Obstet Gynecol Scand. 2014;93(4):335–44.
https://doi.org/10.1111/aogs.12333 DOI: https://doi.org/10.1111/aogs.12333
Yang X, Chai M, Xia L, et al. Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: a randomized controlled clinical trial. Acta Obstet Gynecol Scand. 2023;102(7):950–9.
https://doi.org/10.1111/aogs.14567 DOI: https://doi.org/10.1111/aogs.14567
Prescott LS, Vergote I, Sun CC, et al. Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 cohort. Int J Gynecol Cancer. 2023;33(1):1–9.
https://doi.org/10.1136/ijgc-2022-003947 DOI: https://doi.org/10.1136/ijgc-2022-003947
Hunsicker O, Gericke S, Graw JA, et al. Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer. Transfusion. 2019;59(12):3589–600.
https://doi.org/10.1111/trf.15552 DOI: https://doi.org/10.1111/trf.15552
Cata JP, Wang H, Gottumukkala V, et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701.
https://doi.org/10.1093/bja/aet068 DOI: https://doi.org/10.1093/bja/aet068
Prescott LS, Aloia TA, Brown AJ, et al. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol. 2015;136(1):65–70.
https://doi.org/10.1016/j.ygyno.2014.11.009 DOI: https://doi.org/10.1016/j.ygyno.2014.11.009
Connor JP, O’Shea A, McCool K, et al. Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian cancer; potential impact of patient blood management on cancer outcomes. Gynecol Oncol. 2018;151(2):294–8.
https://doi.org/10.1016/j.ygyno.2018.08.040 DOI: https://doi.org/10.1016/j.ygyno.2018.08.040
Zhang H, Wu X, Xu Z, et al. Impact of perioperative red blood cell transfusion on postoperative recovery and long-term outcome in patients undergoing surgery for ovarian cancer: a propensity score-matched analysis. Gynecol Oncol. 2020;156(2):439–45.
https://doi.org/10.1016/j.ygyno.2019.12.006 DOI: https://doi.org/10.1016/j.ygyno.2019.12.006
Shander A, Hardy JF, Ozawa S, et al. A global definition of patient blood management. Anesth Analg. 2022;135(3):476–88.
https://doi.org/10.1213/ANE.0000000000005873 DOI: https://doi.org/10.1213/ANE.0000000000005873
Fowler H, Law J, Tham SM, et al. Impact on blood loss and transfusion rates following administration of tranexamic acid in major oncological abdominal and pelvic surgery: a systematic review and meta-analysis. J Surg Oncol. 2022;126(3):609–21.
https://doi.org/10.1002/jso.26900 DOI: https://doi.org/10.1002/jso.26900
Fotopoulou C, Planchamp F, Aytulu T, et al. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer. 2021;31(9):1199–206.
https://doi.org/10.1136/ijgc-2021-002951 DOI: https://doi.org/10.1136/ijgc-2021-002951
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. WHO/NMH/NHD/MNM/11.1. Available from: https://iris.who.int/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf [Cited date: 11 March 2024]
Munoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233–47.
https://doi.org/10.1111/anae.13773 DOI: https://doi.org/10.1111/anae.13773
Foley OW, Vega B, Roque D, et al. Characterization of pre-operative anemia in patients undergoing surgery by a gynecologic oncologist and association with post-operative complications. Int J Gynecol Cancer. 2023;33(11):1778–85.
https://doi.org/10.1136/ijgc-2023-004539 DOI: https://doi.org/10.1136/ijgc-2023-004539
Munoz M, Laso-Morales MJ, Gomez-Ramirez S, et al. Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery. Anaesthesia. 2017;72(7):826–34.
https://doi.org/10.1111/anae.13840 DOI: https://doi.org/10.1111/anae.13840
Ludwig H, Muldur E, Endler G, et al. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013;24(7):1886–92.
https://doi.org/10.1093/annonc/mdt118 DOI: https://doi.org/10.1093/annonc/mdt118
O’Shea A, McCool K, Harrison R, et al. Neoadjuvant chemotherapy is associated with more anemia and perioperative blood transfusions than primary debulking surgery in women with advanced stage ovarian cancer. Gynecol Oncol. 2018;150(1):19–22.
https://doi.org/10.1016/j.ygyno.2018.05.014 DOI: https://doi.org/10.1016/j.ygyno.2018.05.014
Richards T, Musallam KM, Nassif J, et al. Impact of preoperative anaemia and blood transfusion on postoperative outcomes in gynaecological surgery. PLoS One. 2015;10(7):e0130861.
https://doi.org/10.1371/journal.pone.0130861 DOI: https://doi.org/10.1371/journal.pone.0130861
Froessler B, Palm P, Weber I, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41–6.
https://doi.org/10.1097/SLA.0000000000001646 DOI: https://doi.org/10.1097/SLA.0000000000001646
Shander A, Corwin HL, Meier J, et al. Recommendations from the international consensus conference on anemia management in surgical patients (ICCAMS). Ann Surg. 2023;277(4):581–90.
https://doi.org/10.1097/SLA.0000000000005721 DOI: https://doi.org/10.1097/SLA.0000000000005721
Nelson G, Altman AD, Nick A, et al. Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations – part I. Gynecol Oncol. 2016;140(2):313–22.
https://doi.org/10.1016/j.ygyno.2015.11.015 DOI: https://doi.org/10.1016/j.ygyno.2015.11.015
Doyle DJ, Hendrix JM, Garmon EH. American society of anesthesiologists classification. Treasure Island, FL: StatPearls; 2023.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
https://doi.org/10.1097/01.sla.0000133083.54934.ae DOI: https://doi.org/10.1097/01.sla.0000133083.54934.ae
Harter P, Sehouli J, Lorusso D, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822–32.
https://doi.org/10.1056/NEJMoa1808424 DOI: https://doi.org/10.1056/NEJMoa1808424
Wallace SK, Halverson JW, Jankowski CJ, et al. Optimizing blood transfusion practices through bundled intervention implementation in patients with gynecologic cancer undergoing laparotomy. Obstet Gynecol. 2018;131(5):891–8.
https://doi.org/10.1097/AOG.0000000000002463 DOI: https://doi.org/10.1097/AOG.0000000000002463
Morris FJD, Fung YL, Craswell A, et al. Outcomes following perioperative red blood cell transfusion in patients undergoing elective major abdominal surgery: a systematic review and meta-analysis. Br J Anaesth. 2023;131(6):1002–13.
https://doi.org/10.1016/j.bja.2023.08.032 DOI: https://doi.org/10.1016/j.bja.2023.08.032
Kengsakul M, Nieuwenhuyzen-de Boer GM, Udomkarnjananun S, et al. Factors predicting 30-day grade IIIa-V Clavien-Dindo classification complications and delayed chemotherapy initiation after cytoreductive surgery for advanced-stage ovarian cancer: a prospective cohort study. Cancers (Basel). 2022;14(17):4181.
https://doi.org/10.3390/cancers14174181 DOI: https://doi.org/10.3390/cancers14174181
Bojesen RD, Eriksen JR, Vogelsang RP, et al. The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer. Colorectal Dis. 2021;23(10):2550–8.
https://doi.org/10.1111/codi.15789 DOI: https://doi.org/10.1111/codi.15789
Dickson EA, Ng O, Keeler BD, et al. The ICaRAS randomised controlled trial: intravenous iron to treat anaemia in people with advanced cancer – feasibility of recruitment, intervention and delivery. Palliat Med. 2023;37(3):372–83.
https://doi.org/10.1177/02692163221145604 DOI: https://doi.org/10.1177/02692163221145604
Kalra PR, Cleland JGF, Petrie MC, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022;400(10369):2199–209.
https://doi.org/10.1016/S0140-6736(22)02083-9 DOI: https://doi.org/10.1016/S0140-6736(22)02083-9
Neef V, Baumgarten P, Noone S, et al. The impact of timing of intravenous iron supplementation on preoperative haemoglobin in patients scheduled for major surgery. Blood Transfus. 2022;20(3):188–97.
Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet. 2019;393(10187):2201–12.
https://doi.org/10.1016/S0140-6736(18)32555-8 DOI: https://doi.org/10.1016/S0140-6736(18)32555-8
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anna Norbeck, Jesper Bengtsson, Susanne Malander, Mihaela Asp, Päivi Kannisto
This work is licensed under a Creative Commons Attribution 4.0 International License.
